NCT00083486终止3 期
Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 终止
- 试验地点
- 23
研究概览
简要总结
The purpose of this study is to determine the effectiveness of different doses of epoetin alfa for treating anemia in patients who have cancer; or patients who no longer have any signs of cancer, but remain anemic as a result of their treatment. These patients should not be currently receiving chemotherapy or radiotherapy. A subject's participation in the study will last approximately 6 months. Subjects will receive weekly doses of epoetin alfa or placebo. Their hemoglobin will be tested every week.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Body weight >/=99 lbs
- •Anemia results from cancer, chemotherapy, radiotherapy or an association with hormonal therapy or immunotherapy
- •Screening hemoglobin level of </=11.0 g/dL for men or </=10.0 for women
排除标准
- 未提供
研究者
研究点 (23)
Loading locations...
相似试验
终止
3 期
Treatment of Anemic Patients With Cancer Who Are Not Receiving Chemotherapy or RadiotherapyCancerAnemiaNCT00083434Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
已完成
不适用
Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2)NeoplasmsAnemiaNCT00398749Janssen-Cilag B.V.1,927
终止
不适用
Search for Predictive Markers of Efficacy of ESAs in Patients With Non-myeloid Malignancies or Myelodysplastic SyndromeMyelodysplastic SyndromesAnemiaHemopathiesNCT01546337Rennes University Hospital30
已完成
4 期
Epoetin Alfa (Hemax®) Phase IV Study in Chemotherapy Induced AnemiaAntineoplastic Chemotherapy Induced AnemiaNCT01374373Bio Sidus SA30
已完成
2 期
Erythropoietin for Management of Anemia Caused by ChemotherapyDiffuse Large B-cell LymphomaNCT02890602Kosin University Gospel Hospital53